cholinergic activity may also contribute to the observed reactions.
Until clinical operational criteria for diagnosing senile dementia of Lewy body type are validated it is not possible to predict accurately which of the growing number of confused and demented elderly patients may be at increased risk of neuroleptic sensitivity. Probably a significant minority of patients with senile dementia of Lewy body type will erroneously meet currently accepted criteria for a diagnosis of possible Alzheimer's disease and in others there will be a misdiagnosis of vascular dementia. A preliminary evaluation of the proposed clinical criteria for senile dementia of Lewy body type (box) in a mixed population of demented patients indicates a sensitivity of 85% and a specificity of 96%, with neuropathological diagnosis as-the validating criterion (McKeith et al, unpublished data).
Acute confusion and fluctuating cognitive impairment with associated hallucinations and delusions without an identifiable underlying cause typifies some, but not all, presentations of senile dementia of Lewy body type. Patients will potentially be seen in accident and emergency departments; medical, geriatric, and psychogeriatric clinics; and in general practice. A degree of caution may be advised in prescribing neuroleptics for these patients, and if sudden deterioration occurs in such circumstances the possibility of the neuroleptic sensitivity syndrome associated with senile dementia of Lewy body type should be considered. Increased morbidity and mortality are associated with such reactions, the management of which may be similar to that of the neuroleptic malignant syndrome.
Introduction
Diabetic retinopathy remains an important public health concern. In the most definitive epidemiological study to date the yearly incidence of blindness due to diabetes mellitus was found to be 3-3 per 100000 population, or around 1600 cases for England and Wales.' Despite intensive research effort the pathogenic mechanisms important to the initiation and progression of-diabetic retinopathy are still poorly understood. It is clear that whatever humoral factors influence the microcirculation it remains to be explained why it is the retina that develops capillary occlusion, exudates, microaneurysms, haemorrhages, and new vessel formation whereas other microcirculations do not. The other important site of microangiopathic insult is the kidney. There the pathogenic mechanisms are becoming clearer as it has become apparent that hyperperfusion of the glomerulus is central to the progression ofdiabetic glomerulonephropathy.2 With the introduction of the laser-Doppler velocimeter developed by Riva et al it has been possible to measure the velocity of the blood flow in large retinal vessels objectively, reproducibly, and non-invasively.3 This together with the determination of vessel diameters by computerised image analysis has allowed a precision in the study ofthe parameters of retinal blood flow not hitherto possible. We present our study of the haemodynamic changes in diabetic retinopathy in a cross sectional population of diabetic patients.
Subjects and methods
Twenty four non-diabetic subjects and 76 diabetic patients were investigated (see table I ). The nondiabetics were recruited from the departmental staff and accompanying persons of the diabetic patients attending the diabetic retinopathy clinic. The diabetic patients were recruited from the diabetic retinopathy clinic. All diabetic patients aged lation of the conductance."6 The resistance of a circulation (mm Hgld/min) is its ability to resist flow. Its value is the reciprocal of the conductance."5
STATISTICAL METHODS
One way analysis of variance was used to define whether significant differences existed between the different groups with respect to the basic parameters of retinal blood flow. It was then that Student's t test was used to test for the differences in each haemodynamic parameter for the retinopathy groups in comparison with non-diabetic controls and the no retinopathy diabetic group. One way analysis of variance together with a conservative multiple comparison test (Scheffe's test) was used for comparing differences in retinal blood flow between non-diabetic controls, no retinopathy group, untreated diabetic retinopathy (background, pre-proliferative, and proliferative), and pan-retinal photocoagulation groups. The effects of the possible confounding variables of age, sex, systolic blood pressure, diastolic blood pressure, mean arterial blood pressure, blood glucose concentration, haemoglobin Al value, intraocular pressure, and type and duration of diabetes mellitus on the parameters of retinal blood flow were determined by stepwise multiple linear regression multivariate analysis using Minitab data analysis software (Minitab Inc, 1989).
Results
A summary of the clinical data is shown in table I. The non-diabetic controls were significantly younger than the no retinopathy group (p=003), pre-proliferative retinopathy group (p<0-001), and the proliferative retinopathy subjects (p=0003). There was no significant difference in ages between the diabetic groups. Systolic and diastolic blood pressures were significantly higher (p<0-012) in all diabetic retinopathy groups when compared with the non-diabetic control group. With the exception of the proliferative retinopathy subjects, in whom diastolic blood pressure was higher than in the no retinopathy group (p=0 01), there were no significant differences in systolic and diastolic blood pressures among the diabetic groups. The mean arterial pressure (p<002) and perfusion pressure (p<0003) were higher in the diabetic retinopathy groups when compared with the non-diabetic control subjects. The proliferative retinopathy mean arterial blood pressure (p=0-016) and perfusion pressure (p=0 017) were higher than in the no retinopathy group. No other significant differences in mean arterial *p<OOO1 Compared with all other groups pressure and perfusion pressure were noted within the diabetic groups. There were no significant differences in intraocular pressure.
The clinical data pertinent to the diabetic subjects are summarised in table II. In comparison with the no retinopathy group there were no significant differences in duration of diabetes, haemoglobin Al value, and blood glucose concentration at the time of blood flow measurement.
Analysis of variance showed that there were intergroup differences in Vma, (F= 11-95 , p<0 005, df=3).
Although there were no significant differences between the non-diabetic controls, no retinopathy group, and untreated retinopathy group, a trend for an increase in Haemoglobin AI (%) 9-0 (3-0) 9-0 (2-2) 9-8 (2-5) 9-9 (2-8) 9 -1 (1-9)
Plasmaglucose(mmol/1) 
Discussion
This study showed hyperperfusion in the diabetic retinal circulation in all groups of untreated diabetic retinopathy in comparison with non-diabetic controls and diabetic patients with no retinopathy. In comparison with diabetic subjects with no retinopathy retinal blood flow was higher by 33 2% in background, 69-4% in pre-proliferative, and 50-1% in proliferative diabetic retinopathy. The observation that the conductance ofthe retinal circulation was increased in diabetic retinopathy shows that there is hyperperfusion even when the systemic blood pressure and ocular perfusion pressure are normal. Interestingly, there was a significant reduction in retinal blood flow and conductance after pan-retinal photocoagulation.
Other studies using the mean circulation time of fluorescein have also suggested an increase in retinal blood flow in diabetic retinopathy.47 Grunwald et al BMJ VOLUME 305
19 SEPTEMBER 1992 :11 using laser-Doppler velocimetry showed no significant changes in retinal blood flow in diabetic retinopathy, though a non-significant increase in retinal blood flow of 16-0% retinopathy (fig 4) . The earliest changes in diabetic retinopathy are thickening of the basement membrane and pericyte loss. Pericytes are very important in the regulation of blood flow since they possess contractile properties allowing changes in the vessel lumen to regulate blood flow.20"2 At the capillary level in diabetes there is increased blood viscosity, decreased red cell deformability, and increased platelet aggregation.2223 These lead to decreased capillary blood flow and even thrombosis in the smallest vessels of the retinal circulation. It is worth noting that both aspirin and ticlopidine reduce the rate of microaneurysm formation in early retinopathy, which could be attributed to the platelet inhibitory antithrombotic effect of these drugs.2425
The overall effect of basement membrane thickening, decreased capillary perfusion, and the biochemical effects of hyperglycaemia is capillary closure. The resultant retinal ischaemia is a potent stimulus for an increase in retinal blood flow; indeed, areas of dilated capillaries in areas adjacent to capillary drop out are often seen in fluorescein angiography. It is thought that retinal ischaemia leading to the production of angiogenic and vasoproliferative factors is the main stimulus for new vessel formation. 26 The increase in flow at the edge of the area ofcapillary closure results in an increment in shear stress to the vessel wall27 as: wall shear stress=(4riQ)/(nR3), where r=viscosity, Q= volume flow, R=radius.
The relations in this equation help us to understand one of the mechanisms behind capillary damage in diabetes. Increased flow, increased viscosity, and capillary closure -all of which occur in diabetes -tend to increase shear stress. Injury to the endothelium of a vessel can result from an increase in shear stress alone. 28 Tooke postulated that increased glycation and thickening of the basement membrane results in "locking" of the vessel.29 This would tend to increase shear stress since the vessel diameter is unable to change.
Hyperperfusion is also associated with increased capillary pressure since the systemic blood pressure is more easily transmitted to the microcirculation in the presence of dilated vasculature. The circumferential stress in a vessel is directly proportional to the perfusion pressure and radius of the vessel and inversely proportional to the thickness of the vessel wall.3" It is conceivable that in larger vessels of the retinal circulation there is circumferential stress damage to the vessel wall and a continuing propensity to dilatation. Since the tension in a wall resisting the distension pressure in a vessel is inversely proportional to the radius (Laplace's law) an increase in wall tension is required to counterbalance the distending pressure in a dilated vessel. 27 The required wall tension is not attained so there is a propensity towards dilatation with subsequent hyperperfusion. The capillary hypertension and shear stress changes will also result in a net increase in fluid leaving the retinal capillaries (Starling's forces); this would contribute to retinal oedema, especially as there is no lymphatic circulation to drain away the excess interstitial fluid."' This is then manifested by retinal exudates and oedema leading, in the macular area, to diabetic maculopathy.
There is evidence of abnormal autoregulation of the retinal circulation in diabetes which can lead to hyperperfusion.3'33 The increased conductance may be due to the autoregulatory response of the retinal circulation to retinal ischaemia; indeed, the conductance increases with the degree of ischaemia. Another explanation is that the retinal circulation in diabetic retinopathy is abnormally regulating to a normal perfusion pressure leading to hyperperfusion. Both hyperglycaemia and hypertension lead to hyperperfusion in the retinal circulation." 35 Although it is clear from this study that there is a relation between increasing severity of retinopathy and hyperperfusion in the retinal circulation, it is difficult to ascertain whether this reflects a pathogenic mechanism or a covariable in association with increasing retinal ischaemia in the presence of a disturbed diabetic metabolism. The haemodynamic model proposed remains speculative since this study determined haemodynamic changes at a single point in time rather than prospectively. Tooke has formulated a model for microangiopathic damage in diabetes in which increased blood flow is important.29 CLINICAL FACTORS Several clinical factors have been shown to influence the progression of diabetic retinopathy. Hypertension was found to be a significant risk factor for the incidence and progression of diabetic retinopathy in several studies. [36] [37] [38] In the study by Klein et al there was a significant relation between the incidence and progression of diabetic retinopathy and blood pressure in insulin dependent diabetic subjects; comparing the highest with the lowest quartile of systolic blood pressure, the relative risk ratios were 1-8 for the incidence of any retinopathy and 3-6 for progression to proliferative diabetic retinopathy. Pregnancy in diabetic patients is often associated with a deterioration in retinopathy.39 Recent work indicates that retinal blood flow is increased by 110% in diabetic pregnancies. ' Further evidence for hyperperfusion having an important aetiological role in the progression of diabetic retinopathy comes from the observations that raised intraocular pressure and unilateral carotid stenosis, both of which reduce retinal blood flow, tend to protect against diabetic retinopathy.4'42 A similar BMJ VOLUME 305 situation occurs with respect to diabetic renal disease since renal artery stenosis protects against diabetic glomerulopathy.43 Brenner's original hypothesis that hyperperfusion of the glomerulus is important to the progression of diabetic nephropathy4 has in effect been validated as it has been shown that treatment of hypertension reduces the rate of decline of renal function. 45 In conclusion, hyperperfusion of the retinal circulation is present in diabetic retinopathy. The haemodynamic model proposes a central role for hyperperfusion in the pathogenesis of diabetic retinopathy. Since hypertension and hyperglycaemia cause hyperperfusion it is important to control these factors in the overall strategy to reduce the morbidity due to diabetic retinopathy.
We are grateful to Dr G Davies and Dr P Sullivan for the validation of the laser-Doppler velocimeter. This work was supproted by the British Diabetic Association through a group grant to Professor E M Kohner and a fellowship of the Juvenile Diabetes Foundation to Dr V Patel. We have received a report of a very important case tried before his Honour Judge Bacon, at the Bloomsbury County Court. The claim was for £3 5s., balance of £5 5s., the price of an electric belt (Harness's patent) supplied by the Medical Battery Company to Mr. Jeffery; and the defendant, by way of counter-claim, sought to have an I 0 U for £3 5s. delivered up to him, and the sum of £2 cash returned to him on the following grounds: First, that he was induced to buy the electric belt through misrepresentation; and, secondly, that there was no good consideration for the contract into which he had entered with the plaintiff company. The evidence given by an electric expert was to the effect that in the electric belt sold no electricity passed through the body in any way whatever, but only along the webbing of the belt and over the skin surface, so that electrically the influence was useless. 
